A comprehensive in silico analysis for identification of therapeutic epitopes in HPV16, 18, 31 and 45 oncoproteins

NetMHCpan-4.0: Improved Peptide–MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data

(2017) Vanessa Jurtz et al.   JOURNAL OF IMMUNOLOGY

Tumour virus vaccines: hepatitis B virus and human papillomavirus

(2017) Margaret Stanley   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

Identification and characterization of enhancer agonist human cytotoxic T-cell epitopes of the human papillomavirus type 16 (HPV16) E6/E7

(2017) Kwong Y. Tsang et al.   VACCINE

The role of integration in oncogenic progression of HPV-associated cancers

(2017) Alison A. McBride et al.   PLoS Pathogens

Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies

(2016) P Vici et al.   Expert Review of Vaccines

Major histocompatibility complex linked databases and prediction tools for designing vaccines

(2016) Satarudra Prakash Singh et al.   HUMAN IMMUNOLOGY

Pan-Specific Prediction of Peptide–MHC Class I Complex Stability, a Correlate of T Cell Immunogenicity

(2016) Michael Rasmussen et al.   JOURNAL OF IMMUNOLOGY

Modeling of protein–peptide interactions using the CABS-dock web server for binding site search and flexible docking

(2016) Maciej Blaszczyk et al.   METHODS

NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets

(2016) Morten Nielsen et al.   Genome Medicine

Carcinogenic human papillomavirus infection

(2016) Mark Schiffman et al.   Nature Reviews Disease Primers

Gapped sequence alignment using artificial neural networks: application to the MHC class I system

(2015) Massimo Andreatta et al.   BIOINFORMATICS

Identification of immunotherapeutic epitope of E5 protein of human papillomavirus-16: An in silico approach

(2015) Anoop Kumar et al.   BIOLOGICALS

Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification

(2015) Massimo Andreatta et al.   IMMUNOGENETICS

Prediction of Epitope-Based Peptides for Vaccine Development from Coat Proteins GP2 and VP24 of Ebola Virus Using Immunoinformatics

(2015) Pratik Narain Srivastava et al.   International Journal of Peptide Research and Therapeutics

Therapeutic cancer vaccines

(2015) Cornelis J.M. Melief et al.   JOURNAL OF CLINICAL INVESTIGATION

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

(2015) Elmar A. Joura et al.   NEW ENGLAND JOURNAL OF MEDICINE

CABS-dock web server for the flexible docking of peptides to proteins without prior knowledge of the binding site

(2015) Mateusz Kurcinski et al.   NUCLEIC ACIDS RESEARCH

Human papillomavirus molecular biology and disease association

(2015) John Doorbar et al.   REVIEWS IN MEDICAL VIROLOGY

Epitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases

(2015) Jiandong Shi et al.   PLoS One

A novel multi-epitope peptide vaccine against cancer: An in silico approach

(2014) Navid Nezafat et al.   JOURNAL OF THEORETICAL BIOLOGY

The immune epitope database (IEDB) 3.0

(2014) Randi Vita et al.   NUCLEIC ACIDS RESEARCH

Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations

(2014) Faviel F. González-Galarza et al.   NUCLEIC ACIDS RESEARCH

Comprehensive Control of Human Papillomavirus Infections and Related Diseases

(2013) F. Xavier Bosch et al.   VACCINE

L2, the minor capsid protein of papillomavirus

(2013) Joshua W. Wang et al.   VIROLOGY

Cross-roads in the classification of papillomaviruses

(2013) Ethel-Michele de Villiers   VIROLOGY

The E5 proteins

(2013) Daniel DiMaio et al.   VIROLOGY

The papillomavirus E7 proteins

(2013) Ann Roman et al.   VIROLOGY

Human papillomavirus genome variants

(2013) Robert D. Burk et al.   VIROLOGY

Properties of MHC Class I Presented Peptides That Enhance Immunogenicity

(2013) Jorg J. A. Calis et al.   PLoS Computational Biology

Advances in Peptide-based Human Papillomavirus Therapeutic Vaccines

(2012) Tzu-Yu Liu et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer

(2012) Peng Guan et al.   INTERNATIONAL JOURNAL OF CANCER

Global burden of cancers attributable to infections in 2008: a review and synthetic analysis

(2012) Catherine de Martel et al.   LANCET ONCOLOGY

Global Burden of Human Papillomavirus and Related Diseases

(2012) David Forman et al.   VACCINE

A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines

(2012) John T. Schiller et al.   VACCINE

The Biology and Life-Cycle of Human Papillomaviruses

(2012) John Doorbar et al.   VACCINE

Immunization with a poly (lactide co-glycolide) encapsulated plasmid DNA expressing antigenic regions of HPV 16 and 18 results in an increase in the precursor frequency of T cells that respond to epitopes from HPV 16, 18, 6 and 11

(2011) Mark Matijevic et al.   CELLULAR IMMUNOLOGY

Novel oligomannose liposome-DNA complex DNA vaccination efficiently evokes anti-HPV E6 and E7 CTL responses

(2011) Masahito Mizuuchi et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

NetMHCcons: a consensus method for the major histocompatibility complex class I predictions

(2011) Edita Karosiene et al.   IMMUNOGENETICS

HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX® B/E

(2011) Robert Paris et al.   VACCINE

CD4+ T Cell Epitope Discovery and Rational Vaccine Design

(2010) Daniela Santoro Rosa et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

Peptide binding predictions for HLA DR, DP and DQ molecules

(2010) Peng Wang et al.   BMC BIOINFORMATICS

Innovative bioinformatic approaches for developing peptide-based vaccines against hypervariable viruses

(2010) Danylo Sirskyj et al.   IMMUNOLOGY AND CELL BIOLOGY

Induction of protective immunity against MHC class I-deficient, HPV16-associated tumours with peptide and dendritic cell-based vaccines

(2010) Reinis   INTERNATIONAL JOURNAL OF ONCOLOGY

A Conserved E7-derived Cytotoxic T Lymphocyte Epitope Expressed on HumanPapillomavirus16-transformed HLA-A2+Epithelial Cancers

(2010) Angelika B. Riemer et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

A Vaccine Encoding Conserved Promiscuous HIV CD4 Epitopes Induces Broad T Cell Responses in Mice Transgenic to Multiple Common HLA Class II Molecules

(2010) Susan Pereira Ribeiro et al.   PLoS One

Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments

(2010) Hans-Ulrich Bernard et al.   VIROLOGY

The PickPocket method for predicting binding specificities for receptors based on receptor pocket similarities: application to MHC-peptide binding

(2009) Hao Zhang et al.   BIOINFORMATICS

Derivation of an amino acid similarity matrix for peptide:MHC binding and its application as a Bayesian prior

(2009) Yohan Kim et al.   BMC BIOINFORMATICS

NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction

(2009) Morten Nielsen et al.   BMC BIOINFORMATICS

Prediction of MHC-Peptide Binding: A Systematic and Comprehensive Overview

(2009) Esther Lafuente et al.   CURRENT PHARMACEUTICAL DESIGN

HLA class I supertypes: a revised and updated classification

(2008) John Sidney et al.   BMC IMMUNOLOGY

Cluster intradermal DNA vaccination rapidly induces E7-specific CD8+ T-cell immune responses leading to therapeutic antitumor effects

(2008) S Peng et al.   GENE THERAPY

NetMHCpan, a method for MHC class I binding prediction beyond humans

(2008) Ilka Hoof et al.   IMMUNOGENETICS

NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8–11

(2008) Claus Lundegaard et al.   NUCLEIC ACIDS RESEARCH

An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results

(2008) John T. Schiller et al.   VACCINE

Papillomavirus E6 proteins

(2008) Heather L. Howie et al.   VIROLOGY

A Systematic Assessment of MHC Class II Peptide Binding Predictions and Evaluation of a Consensus Approach

(2008) Peng Wang et al.   PLoS Computational Biology